Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert W Haasnoot

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Opinion in Organ Transplantation|May 31, 2018
How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survivalSebastiaan Heidt, Geert W Haasnoot, Frans H J Claas
Transplant Immunology|September 2, 2015
The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patientsSebastiaan Heidt, Marian D Witvliet, Geert W Haasnoot, et al.
Clinical Transplantation|August 14, 2009
HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathyMargret B Andresdottir, Geert W Haasnoot, Guido G Persijn, et al.
Frontiers in Immunology|June 20, 2022
Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ TransplantationIlse Gille, Frans H J Claas, Geert W Haasnoot, et al.
Journal of Reproductive Immunology|August 2, 2015
Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnanciesLisa E E L O Lashley, Geert W Haasnoot, Marijke Spruyt-Gerritse, et al.
Kidney International|September 27, 2017
Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patientsSebastiaan Heidt, Geert W Haasnoot, Jon J van Rood, et al.
Transplantation|November 10, 2005
Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry dataMargret B Andresdottir, Geert W Haasnoot, Ilias I N Doxiadis, et al.
Immunogenetics|July 13, 2014
Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availabilityMoshe Israeli, Machteld Oudshoorn, Geert W Haasnoot, et al.
HLA|May 2, 2023
A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for luminex single antigen bead assays of two different vendorsGonca E Karahan, Geert W Haasnoot, Kim Voogt-Bakker, et al.
Frontiers in Immunology|July 12, 2021
Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable MismatchesSebastiaan Heidt, Geert W Haasnoot, Marissa J H van der Linden-van Oevelen, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Opinion in Organ Transplantation|May 31, 2018
How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survivalSebastiaan Heidt, Geert W Haasnoot, Frans H J Claas
Transplant Immunology|September 2, 2015
The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patientsSebastiaan Heidt, Marian D Witvliet, Geert W Haasnoot, et al.
Clinical Transplantation|August 14, 2009
HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathyMargret B Andresdottir, Geert W Haasnoot, Guido G Persijn, et al.
Frontiers in Immunology|June 20, 2022
Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ TransplantationIlse Gille, Frans H J Claas, Geert W Haasnoot, et al.
Journal of Reproductive Immunology|August 2, 2015
Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnanciesLisa E E L O Lashley, Geert W Haasnoot, Marijke Spruyt-Gerritse, et al.
Kidney International|September 27, 2017
Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patientsSebastiaan Heidt, Geert W Haasnoot, Jon J van Rood, et al.
Transplantation|November 10, 2005
Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry dataMargret B Andresdottir, Geert W Haasnoot, Ilias I N Doxiadis, et al.
Immunogenetics|July 13, 2014
Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availabilityMoshe Israeli, Machteld Oudshoorn, Geert W Haasnoot, et al.
HLA|May 2, 2023
A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for luminex single antigen bead assays of two different vendorsGonca E Karahan, Geert W Haasnoot, Kim Voogt-Bakker, et al.
Frontiers in Immunology|July 12, 2021
Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable MismatchesSebastiaan Heidt, Geert W Haasnoot, Marissa J H van der Linden-van Oevelen, et al.
Pageof 8